Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. (Q45135207)

9 December 2017

title

Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. (English)

1 reference

9 December 2017

0 references

Stefanie M Bode-Böger

1 reference

9 December 2017

Karsten Sydow

1 reference

9 December 2017

Burkhard Hornig

1 reference

9 December 2017

Naoshi Arakawa

1 reference

9 December 2017

Dimitrios Tsikas

1 reference

9 December 2017

Thomas Münzel

1 reference

9 December 2017

Rainer H Böger

1 reference

9 December 2017

language of work or name

1 reference

1 May 2004

1 reference

9 December 2017

1 reference

9 December 2017

1 reference

9 December 2017

1 reference

9 December 2017

page(s)

93-101

1 reference

Homocysteine and its disulfide derivatives: a suggested consensus terminology

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

Direct measurement of nitric oxide generation from nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM538OA

10.1191/1358863X04VM538OA

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference